Endpoint definition
↥| Name | SYSTSCLE_STRICT |
|---|---|
| Long name | Systemic sclerosis,strict definition |
| KELA reimboursements codes | ANY |
| KELA reimbursements | ICD-10: M34 |
| Conditions required | SYSTSCLE_ICD10 |
| First defined in version | DF3 |
Systemic sclerosis,strict definition
scleroderma: Scleroderma is a rare autoimmune connective tissue disorder characterized by abnormal hardening of the skin and, sometimes, other organs. It is classified into two main forms: localized scleroderma and systemic sclerosis (SSc), the latter comprising three subsets; diffuse cutaneous SSc (dcSSc), limited cutaneous SSc (lcSSc) and limited SSc (lSSc) (see these terms).
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 107 | 94 | 13 |
| Unadjusted prevalence (%) | 0.05 | 0.08 | 0.01 |
| Mean age at first event (years) | 54.56 | 54.32 | 56.33 |
| Case fatality at 5-years (%) | 2.80 | 1.06 | 15.38 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.0 |
| Recurrence at 6 months (%) | - | - | - |
Survival analyses between endpoints
↥Plot
before Systemic sclerosis,strict definition
after Systemic sclerosis,strict definition
Loading survival analyses plot…
Table
Loading survival analyses table…